A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Diabetic Neuropathic Pain
Interventions
DRUG

ABT-894

6 mg BID tablets, 8 weeks of treatment

DRUG

placebo

BID tablets, 8 weeks of treatment

Trial Locations (29)

8208

Site Reference ID/Investigator# 7911, Sabadell, Barcelona

10115

Site Reference ID/Investigator# 11201, Berlin

11042

Site Reference ID/Investigator# 7229, New Hyde Park

18014

Site Reference ID/Investigator# 6475, Granada

18103

Site Reference ID/Investigator# 6575, Allentown

28211

Site Reference ID/Investigator# 6618, Charlotte

33021

Site Reference ID/Investigator# 6356, Hollywood

33414

Site Reference ID/Investigator# 6358, Wellington

33603

Site Reference ID/Investigator# 6615, Tampa

40225

Site Reference ID/Investigator# 6234, Düsseldorf

58033

Site Reference ID/Investigator# 6238, Nevers

63141

Site Reference ID/Investigator# 6609, St Louis

67100

Site Reference ID/Investigator# 5549, L’Aquila

73103

Site Reference ID/Investigator# 6607, Oklahoma City

77900

Site Reference ID/Investigator# 5554, Olomouc

78229

Site Reference ID/Investigator# 6616, San Antonio

80804

Site Reference ID/Investigator# 7714, Munich

87042

Site Reference ID/Investigator# 5557, Limoges

91106

Site Reference ID/Investigator# 9363, Corbeil-Essonnes

91978

Site Reference ID/Investigator# 6614, Spring Valley

94598

Site Reference ID/Investigator# 6617, Walnut Creek

97980

Site Reference ID/Investigator# 6564, Bad Mergentheim

78229-4801

Site Reference ID/Investigator# 8179, San Antonio

500 03

Site Reference ID/Investigator# 5552, Hradec Králové

760 01

Site Reference ID/Investigator# 5553, Zlín

D - 55116

Site Reference ID/Investigator# 11202, Mainz

06126

Site Reference ID/Investigator# 5558, Perugia

B29 6JD

Site Reference ID/Investigator# 5555, Birmingham

S5 7AU

Site Reference ID/Investigator# 7133, Sheffield

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT00548925 - A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain | Biotech Hunter | Biotech Hunter